
| Image Class: | skin-invert-image |
| Tradename: | 優替帝 |
| Atc Prefix: | L01 |
| Atc Suffix: | DC05 |
| Legal Status: | Rx in China |
| Synonyms: | Epothilone D; desoxyepothilone B |
| Cas Number: | 189453-10-9 |
| Unii: | T0358E0YUF |
| Pubchem: | 447865 |
| Drugbank: | DB17575 |
| C: | 27 |
| H: | 41 |
| N: | 1 |
| O: | 5 |
| S: | 1 |
Utidelone is a pharmaceutical drug for the treatment of metastatic breast cancer. It was approved for use in China in 2021.[1] [2]
Utidelone is a member of the epothilone class of natural products, which are metabolites produced by the soil-dwelling myxobacterium Sorangium cellulosum.[3] It is also known as epothilone D.